Search Results - "Souroujon, M C"

Refine Results
  1. 1

    Peptide modulators of protein-protein interactions in intracellular signaling by Souroujon, Miriam C, Mochly-Rosen, Daria

    Published in Nature biotechnology (01-10-1998)
    “…Signal transduction cascades involve multiple enzymes and are orchestrated by selective protein-protein interactions that are essential for the progression of…”
    Get full text
    Journal Article
  2. 2

    Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels by Liron, T, Seraya, C. Bareket, Ish-Shalom, M, Souroujon, M.C, Neumann, D

    Published in Neuroscience (25-04-2007)
    “…Abstract Alzheimer’s disease (AD) is characterized by extracellular deposits of amyloid beta peptide (Aβ), a peptide that is generated upon proteolytic…”
    Get full text
    Journal Article
  3. 3

    Development of novel therapies for MG: Studies in animal models by Souroujon, M. C., Brenner, T., Fuchs, S.

    Published in Autoimmunity (Chur, Switzerland) (01-08-2010)
    “…Experimental myasthenia gravis (MG) in animals, and in particular experimental autoimmune MG in rodents, serves as excellent models to study possible novel…”
    Get full text
    Journal Article
  4. 4

    Antigen-Specific Modulation of Experimental Myasthenia Gravis: Nasal Tolerization with Recombinant Fragments of the Human Acetylcholine Receptor α -Subunit by Barchan, Dora, Souroujon, Miriam C., Im, Sin-Hyeog, Antozzi, Carlo, Fuchs, Sara

    “…Myasthenia gravis (MG) and experimental autoimmune myasthenia gravis (EAMG) are antibody-mediated autoimmune diseases in which the nicotinic acetylcholine…”
    Get full text
    Journal Article
  5. 5

    Role of Tolerogen Conformation in Induction of Oral Tolerance in Experimental Autoimmune Myasthenia Gravis by Im, Sin-Hyeog, Barchan, Dora, Souroujon, Miriam C, Fuchs, Sara

    Published in The Journal of immunology (1950) (01-10-2000)
    “…We recently demonstrated that oral or nasal administration of recombinant fragments of the acetylcholine receptor (AChR) prevents the induction of experimental…”
    Get full text
    Journal Article
  6. 6

    Sustained in vivo Cardiac Protection by a Rationally Designed Peptide That Causes ε Protein Kinase C Translocation by Dorn, Gerald W., Souroujon, Miriam C., Liron, Tamar, Chen, Che-Hong, Gray, Mary O., Zhou, Hui Zhong, Csukai, Michael, Wu, Guangyu, Lorenz, John N., Mochly-Rosen, Daria

    “…Brief periods of cardiac ischemia trigger protection from subsequent prolonged ischemia (preconditioning). ε Protein kinase C (ε PKC) has been suggested to…”
    Get full text
    Journal Article
  7. 7

    Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis by Asher, O, Kues, WA, Witzemann, V, Tzartos, SJ, Fuchs, S, Souroujon, MC

    Published in The Journal of immunology (1950) (01-12-1993)
    “…The passive transfer of myasthenia gravis by injection of mAb against muscle acetylcholine receptor (AChR) alpha-subunit, results in increased expression of…”
    Get full text
    Journal Article
  8. 8

    Blockade of CD40 Ligand Suppresses Chronic Experimental Myasthenia Gravis by Down-Regulation of Th1 Differentiation and Up-Regulation of CTLA-4 by Im, Sin-Hyeog, Barchan, Dora, Maiti, Prasanta Kumar, Fuchs, Sara, Souroujon, Miriam C

    Published in The Journal of immunology (1950) (01-06-2001)
    “…Myasthenia gravis (MG) and experimental autoimmune MG (EAMG) are T cell-dependent Ab-mediated autoimmune disorders, in which the nicotinic acetylcholine…”
    Get full text
    Journal Article
  9. 9

    Acetylcholine receptor and myogenic factor gene expression in Torpedo embryonic development by Asher, O, Fuchs, S, Souroujon, M C

    Published in Neuroreport (15-08-1994)
    “…The mRNA levels of acetylcholine receptor (AChR) and myogenic factors were followed during embryonic development of Torpedo skeletal muscle and its homologue,…”
    Get more information
    Journal Article
  10. 10

    Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment by Maiti, Prasanta K, Feferman, Tali, Im, Sin-Hyeog, Souroujon, Miriam C, Fuchs, Sara

    Published in Journal of neuroimmunology (01-07-2004)
    “…A syngeneic rat recombinant fragment of the extracellular domain of the acetylcholine receptor (AChR) α-subunit (Rα1–205), administered orally, suppresses…”
    Get full text
    Journal Article
  11. 11

    Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment by Im, S H, Barchan, D, Fuchs, S, Souroujon, M C

    Published in The Journal of clinical investigation (01-12-1999)
    “…Myasthenia gravis (MG) is an autoimmune disorder in which the nicotinic acetylcholine receptor (AChR) is the major autoantigen. In an attempt to develop an…”
    Get full text
    Journal Article
  12. 12

    Mapping of the cAMP‐dependent phosphorylation sites on the acetylcholine receptor by Souroujon, M.C., Neumann, D., Pizzighella, S., Fridkin, M., Fuchs, S.

    Published in The EMBO journal (01-03-1986)
    “…We have synthesized a tetradecapeptide corresponding to residues 354‐367 of the delta‐subunit of Torpedo acetylcholine receptor. This peptide contains the…”
    Get full text
    Journal Article
  13. 13

    Suppression of experimental myasthenia gravis, a B cell‐mediated autoimmune disease, by blockade of IL‐18 by Im, Sin‐Hyeog, Barchan, Dora, Maiti, Prasanta Kumar, Raveh, Lily, Souroujon, Miriam C., Fuchs, Sara

    Published in The FASEB journal (01-10-2001)
    “…Interleukin‐18 (IL‐18) is a pleiotropic proinflammatory cytokine that plays an important role in interferon gamma (IFN‐γ) production and IL‐12‐driven Th1…”
    Get full text
    Journal Article
  14. 14

    Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis by Feferman, Tali, Im, Sin-Hyeog, Fuchs, Sara, Souroujon, Miriam C

    Published in Journal of neuroimmunology (01-07-2003)
    “…The acetylcholine receptor (AChR) is the major autoantigen in the antibody-mediated disease myasthenia gravis (MG) and its animal model experimental autoimmune…”
    Get full text
    Journal Article
  15. 15

    Differences between embryonic and adult Torpedo acetylcholine receptor γ subunit by Souroujon, Miriam C., Carmon, Sara, Safran, Anat, Fuchs, Sara

    Published in FEBS letters (19-08-1991)
    “…Antibodies to a synthetic peptide corresponding to residues 346–359 of the Torpedo acetylcholine receptor (AChR) γ subunit, were employed to compare the adult…”
    Get full text
    Journal Article
  16. 16

    Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis by Im, Sin-Hyeog, Barchan, Dora, Fuchs, Sara, Souroujon, Miriam C

    Published in Journal of neuroimmunology (01-11-2000)
    “…Acetylcholine receptor (AChR) is the major autoantigen in myasthenia gravis (MG) and experimental autoimmune MG (EAMG). Here we analyze the mechanisms involved…”
    Get full text
    Journal Article
  17. 17

    Protective molecular mimicry in experimental myasthenia gravis by Im, Sin-Hyeog, Barchan, Dora, Feferman, Tali, Raveh, Lily, Souroujon, Miriam C, Fuchs, Sara

    Published in Journal of neuroimmunology (01-05-2002)
    “…Protein databases were searched for microbial sequences that bear amino acid similarities with identified T- or B-cell epitopes within the human α-subunit of…”
    Get full text
    Journal Article
  18. 18

    Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle by Souroujon, M C, Mochly-Rosen, D, Gordon, A S, Fuchs, S

    Published in Muscle & nerve (01-05-1983)
    “…Several monoclonal antibodies (mcAbs) elicited against the nicotinic acetylcholine receptor (AChR) from Torpedo react also with skeletal muscle AChR. Such…”
    Get more information
    Journal Article
  19. 19

    Modulation of the anti‐acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor by Barchan, Dora, Asher, Orna, Tzartos, Socrates J., Fuchs, Sara, Souroujon, Miriam C.

    Published in European journal of immunology (01-02-1998)
    “…Myasthenia gravis (MG) is a neuromuscular disorder of man caused by a humoral response to the acetylcholine receptor (AChR). Most of the antibodies in MG and…”
    Get full text
    Journal Article
  20. 20

    Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes by Souroujon, M C, Barchan, D, Fuchs, S

    Published in Immunology letters (1985)
    “…Anti-idiotypes were raised in mice against three well-characterized anti-acetylcholine receptor (AChR) monoclonal antibodies (mcAbs), as well as against…”
    Get more information
    Journal Article